These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Mechanisms of renal hyporesponsiveness to BNP in heart failure. Egom EE; Feridooni T; Hotchkiss A; Kruzliak P; Pasumarthi KB Can J Physiol Pharmacol; 2015 Jun; 93(6):399-403. PubMed ID: 25881664 [TBL] [Abstract][Full Text] [Related]
24. Biodesign of a renal-protective peptide based on alternative splicing of B-type natriuretic peptide. Pan S; Chen HH; Dickey DM; Boerrigter G; Lee C; Kleppe LS; Hall JL; Lerman A; Redfield MM; Potter LR; Burnett JC; Simari RD Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11282-7. PubMed ID: 19541613 [TBL] [Abstract][Full Text] [Related]
26. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Yoshimura M; Yasue H; Morita E; Sakaino N; Jougasaki M; Kurose M; Mukoyama M; Saito Y; Nakao K; Imura H Circulation; 1991 Oct; 84(4):1581-8. PubMed ID: 1914098 [TBL] [Abstract][Full Text] [Related]
27. Effects of synthetic atrial natriuretic peptide on renal function and renin release in acute experimental heart failure. Scriven TA; Burnett JC Circulation; 1985 Oct; 72(4):892-7. PubMed ID: 3161663 [TBL] [Abstract][Full Text] [Related]
28. Hemodynamic and renal effects of low-dose brain natriuretic peptide infusion in humans: a randomized, placebo-controlled crossover study. van der Zander K; Houben AJ; Hofstra L; Kroon AA; de Leeuw PW Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H1206-12. PubMed ID: 12738624 [TBL] [Abstract][Full Text] [Related]
29. Does brain natriuretic peptide have a direct renal effect in human hypertensives? van der Zander K; Houben AJ; Kroon AA; Wierema TK; Fuss-Lejeune MJ; Koster D; de Leeuw PW Hypertension; 2003 Jan; 41(1):119-23. PubMed ID: 12511540 [TBL] [Abstract][Full Text] [Related]
30. Effects of brain natriuretic peptide on renin secretion in normal and hypertonic saline-infused kidney. Akabane S; Matsushima Y; Matsuo H; Kawamura M; Imanishi M; Omae T Eur J Pharmacol; 1991 Jun; 198(2-3):143-8. PubMed ID: 1864303 [TBL] [Abstract][Full Text] [Related]
31. Cardiovascular and renal effects of low dose brain natriuretic peptide infusion in man. La Villa G; Fronzaroli C; Lazzeri C; Porciani C; Bandinelli R; Vena S; Messeri G; Franchi F J Clin Endocrinol Metab; 1994 May; 78(5):1166-71. PubMed ID: 8175974 [TBL] [Abstract][Full Text] [Related]
32. Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis. Komeichi H; Moreau R; Cailmail S; Gaudin C; Lebrec D J Hepatol; 1995 Mar; 22(3):319-25. PubMed ID: 7608483 [TBL] [Abstract][Full Text] [Related]
33. Divergent effects of ANP and BNP in acute heart failure: evidence for a putative BNP-selective receptor? Brunner-La Rocca HP; Woods RL; Kaye DM; Hastings J; Thomas CJ; Lambert E; Esler MD J Hypertens; 2002 Jun; 20(6):1195-201. PubMed ID: 12023691 [TBL] [Abstract][Full Text] [Related]
35. Effects of alpha-human natriuretic peptide on renal hemodynamics and diuresis in dogs and perfused rat kidneys. Watanabe I; Goto F Jpn Circ J; 1994 Feb; 58(2):136-42. PubMed ID: 8196155 [TBL] [Abstract][Full Text] [Related]
36. Brain natriuretic peptide is not reno-protective during renal ischemia-reperfusion injury in the rat. Kim T; Harman PK; Lyons R; Gaskins RB; Hobson CE; Evans SM; Tribble CG; Ejaz AA; Beaver TM J Surg Res; 2010 Nov; 164(1):e13-9. PubMed ID: 20851423 [TBL] [Abstract][Full Text] [Related]
37. Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans. Jensen KT; Carstens J; Pedersen EB Am J Physiol; 1998 Jan; 274(1):F63-72. PubMed ID: 9458824 [TBL] [Abstract][Full Text] [Related]
38. Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure. Lisy O; Lainchbury JG; Leskinen H; Burnett JC Hypertension; 2001 Apr; 37(4):1089-94. PubMed ID: 11304508 [TBL] [Abstract][Full Text] [Related]
39. TRV120027, a novel β-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure. Boerrigter G; Soergel DG; Violin JD; Lark MW; Burnett JC Circ Heart Fail; 2012 Sep; 5(5):627-34. PubMed ID: 22891045 [TBL] [Abstract][Full Text] [Related]